BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  STERIS Raises Dividend to $0.69 per share

  July 30, 2026

   · 

  4 min read
• Press Releases

  Cellectis to Report Second Quarter Financial Results on August 6, 2026

  July 30, 2026

   · 

  1 min read
• Press Releases

  FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026

  July 30, 2026

   · 

  1 min read
• Press Releases

  Aptar Reports Second Quarter 2026 Results

  July 30, 2026

   · 

  20 min read
• 

  FDA

  Replimune overcomes ‘messy data’ to secure positive adcomm vote for melanoma therapy

  The FDA’s Cellular, Tissue and Gene Therapies advisory committee voted 10 to 3 in favor of Replimune’s immunotherapy for advanced melanoma in combination with Bristol Myers Squibb’s Opdivo, but trial design was a major sticking point as the panel deliberated.

  July 30, 2026

   · 

  5 min read

   · 

  Michael Gibney
• Press Releases

  Noveris Health Sciences Joins BioAlberta

  July 30, 2026

   · 

  4 min read
• Press Releases

  Medexus Schedules First Fiscal Quarter 2027 Conference Call

  July 30, 2026

   · 

  3 min read
• Press Releases

  DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

  July 30, 2026

   · 

  11 min read
• Press Releases

  Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference

  July 30, 2026

   · 

  1 min read
• Press Releases

  Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

  July 30, 2026

   · 

  2 min read